{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-040182","form_type":"8-K","ticker":"DRIO","cik":"0001533998","company_name":"DarioHealth Corp.","filed_at":"2025-04-28T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.661326+00:00","generated_at":"2026-05-23T04:56:59.795868+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.15,"confidence":"high","headline":"DarioHealth shareholders approve up to 51.7M share issuance and warrant repricing","bullets":["Vote passed 21.4M for, 0.44M against, 0.08M abstain at special meeting on April 28, 2025.","Authorizes conversion of 25,605 Series D-3 preferred shares into 33.96M common shares from Dec 2024/Jan 2025 private placements.","Also authorizes up to 13.58M common shares as dividends on Series D-3 preferred and up to 4.18M shares for lock-up agreements with B/C preferred holders.","Warrant repricing: 584,882 warrants to Avenue at $0.7208/share; loan conversion up to $2M at $0.8650/share."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-040182","json":"https://secwatch.observer/filing/0001104659-25-040182.json","markdown":"https://secwatch.observer/filing/0001104659-25-040182.md","text":"https://secwatch.observer/filing/0001104659-25-040182.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1533998/000110465925040182/0001104659-25-040182-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1533998/000110465925040182/tm2513371d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-23T04:56:59.795868+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}